← Back to Search

Topical Gel

VB-1953 topical gel - 2% BID for Acne

Phase 2

Waitlist Available

Research Sponsored by Vyome Therapeutics Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Dose-ranging Study in the Treatment of Acne Vulgaris,

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Inflammatory lesion counts

Secondary outcome measures

Investigator's Global Assessment of Inflammatory Acne (IGA) score

Percent change in inflammatory lesion counts

Trial Design

4Treatment groups

Experimental Treatment

Placebo Group

Group I: VB-1953 topical gel - 2% QDExperimental Treatment1 Intervention

VB-1953 topical gel - 2% QD

Group II: VB-1953 topical gel - 2% BIDExperimental Treatment1 Intervention

VB-1953 topical gel - 2% BID

Group III: VB-1953 VehiclePlacebo Group1 Intervention

VB-1953 topical gel- 0% (Vehicle) BID

Group IV: VB-1953 topical gel- 0% (Vehicle) QDPlacebo Group1 Intervention

VB-1953 topical gel- 0% (Vehicle) QD

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Vyome Therapeutics Inc.Lead Sponsor

Dr. Shilpi JainStudy DirectorVyome Therapeutics Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

2019. "Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03900676.

All > Acne

~80 spots leftby May 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.